Brinzolamide Ophthalmic Dosage
Medically reviewed by Drugs.com. Last updated on May 6, 2024.
Applies to the following strengths: 1%
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Intraocular Hypertension
One drop in the affected eye(s) three times a day
Comments:
- If more than one topical ophthalmic drug is being used, the drugs should be administered at least 10 minutes apart.
Use: Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Usual Adult Dose for Glaucoma (Open Angle)
One drop in the affected eye(s) three times a day
Comments:
- If more than one topical ophthalmic drug is being used, the drugs should be administered at least 10 minutes apart.
Use: Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Renal Dose Adjustments
Severe renal impairment (CrCl less than 30 mL/min): Not recommended
Liver Dose Adjustments
Hepatic impairment: Data not available
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Patient advice:
- To minimize systemic absorption, pressure should be applied to the tear duct for two minutes immediately after administration.
- Patients should be instructed to avoid allowing the tip of the container to contact the eye, eyelid, fingers or any other surface.
Storage requirements:
- Store at 4 C to 30 C (39 F to 86 F)
- Shake well before use.
- Discard container 4 weeks after opening.
More about brinzolamide ophthalmic
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.